General Information of Drug (ID: DMG2IE5)

Drug Name
PF-3732010 Drug Info
Synonyms P-cadherin MAb, PF-03072010, PF-03732010
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMG2IE5

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Placental cadherin (CDH3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PF-06671008 DMK19V6 Solid tumour/cancer 2A00-2F9Z Phase 1 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Placental cadherin (CDH3) TTARMD9 CADH3_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT00557505) A Study Of PF-03732010 In Patients With Advanced Solid Tumors. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug id 580366).
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)